Looking to buy the report?


Cancer cachexia is a wasting syndrome, which is characterized by a loss in weight, anorexia, asthenia, and anemia. The pathogenicity of this syndrome is multifactorial, due to complex interactions between tumor and host factors. It is among the common manifestation of the advanced malignant disease, leading to death. Some of the symptoms include involuntary weight loss, skeletal muscle wasting, anorexia/loss of appetite, and lowered quality of life. This disease is also observed among patients with diseases, such as AIDS/HIV, heart failure, emphysema, and kidney failure.

Report Coverage

This report by Mordor Intelligence provides extensive insights of the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases and status of clinical trials across major regions of the world are provided, with data obtained from multiple sources. The report also includes a list of key sponsors having pipeline products for the concerned market.

Cancer Cachexia Clinical Trial Analysis, by Phase and Status

  • The clinical trial analysis for cancer cachexia indicates that there are around XX number of trials under various phases
  • Phase X trials accounted for the majority share
  • The trial data analysis suggests number of ongoing trials and the ones terminated

Cancer Cachexia Clinical Trials Analysis, by Geography

  • By geography, the scope of the report covers the regional assessment for the clinical trials, globally. It covers a concise information of registered clinical trials, in different countries, across several developed and emerging markets
  • Some of the major driving factors include unsuccessful attempts of single therapy. The clinical management of cancer cachexia requires a multidisciplinary and multi-targeted approach. The multimodal therapy also requires “best supportive care”, which includes optimal management of symptoms and careful psychosocial counseling. These factors drive the demand for the development of therapies and increase in clinical pipeline products

Key Sponsors in Cancer Cachexia Clinical Trials

The report will cover analysis on trails and information on key sponsors, companies, and researchers.

Research Methodology

Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and in-house team of research experts. The pipeline assessment reports are generated, based on the information procured from various stake holders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary research and primary research are validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports are continuously updated, to incorporate the most relevant and authentic information to our clients.

Reasons to buy the Report

This report will help you understand

  • The clinical trials that are being conducted worldwide
  • The key products that are under development (Phase I, Phase II, and Phase III)
  • The main areas of research under development (by product, mechanism of action, molecule, delivery, etc.)
  • The average recruitment size in trials
  • Key deals between institutions and industries
  • Gather insights on regional and country-level data
  • Review of dormant and discontinued studies across the category
  • Information on key sponsors and profiles
  • Protocol and design comparisons, to generate the best solution for your product development strategy

1. Introduction

2. Research Methodology

3. Disease Epidemiology and Trends

4. Healthcare Expenditure and R&D Trends

5. Executive Summary

6. Clinical Trials Segmentation, by Phase

                6.1 Phase-III Product Candidates

                6.2 Phase-II Product Candidates

                6.3 Phase-I Product Candidates

7. Clinical Trials, Segmentation, by Status

                7.1 Suspended

                7.2 Terminated

                7.3 Withdrawn

                7.4 Ongoing

                7.5 Completed

                7.6 Other Statuses

8. Pipeline Therapeutic Assessment (Infographic Charts and Brief description)

                8.1. By Clinical Phase and Molecule Type

                8.2. By Clinical Phase and Route of Administration

                8.3 By Sponsor/Collaborator/Institutions

                8.4 By Geography

9. Market Updates

10. Key Sponsor Profiles

11. Sources and Disclaimer

12. About Mordor Intelligence

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?



By submitting, you confirm that you agree to our privacy policy